In vivo Regulation of Brain Dopamine (DA) Receptors by Antidepressants and CNS Stimulants

  • S. Bischoff
  • A. Vassout
  • P. Waldmeier
  • H. Bittiger
Part of the Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology book series (SSNIC)

Abstract

CNS stimulants and some antidepressants are known to activate central DA-ergic transmission, by inhibition of the uptake of DA or by its release from nerve terminals. These effects are well-documented. Surprisingly, they is only sparse information on the effect of these classes of drugs on DA receptors. Recently, we have shown that bupropion (BUP), an antidepressant, can modify the affinity of DA receptors after its acute injection to rats (Bischoff et al., 1984) To further characterize the mode of action of CNS stimulants and DA-activating antidepressants, we studied their effects on in vitro and in vivo (3H)spiperone (SPI) binding.

Keywords

Dopamine Cocaine Methylphenidate Bupropion Reserpine 

References

  1. Bischoff S., Bittiger H. and Krauss J. (1980). In vivo (3H)spiperone binding to the rat hippocampal formation: involvement of dopamine receptors. Eur. J. Pharmacol., 68, 305–315.PubMedCrossRefGoogle Scholar
  2. Bischoff S., Bittiger H., Krauss J.. Vassout A. and Waldmeier P. (1984). Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment. Eur. J. Pharmacol. (in press).Google Scholar
  3. Waldmeier P., Buchle A.-M., Stoecklin K., Fehr B. and Feldtrauer J.-J. (1983). The effects of amfonelic acid on 5-HT metabolism in rat brain. J. Neural Transm., 51, 149–165.CrossRefGoogle Scholar

Copyright information

© The Contributors 1986

Authors and Affiliations

  • S. Bischoff
    • 1
  • A. Vassout
    • 1
  • P. Waldmeier
    • 1
  • H. Bittiger
    • 1
  1. 1.Research Department, Pharmaceuticals DivisionCIBA-GEIGYBaselSwitzerland

Personalised recommendations